Pharma & Biotech

Walgreens Boots Alliance has officially concluded its tenure as a publicly traded company following its full acquisition by private equity...

Shares of Humacyte experienced a dramatic and unexplained surge, climbing more than 20% in a single trading session. This sharp...

A clinical-stage biotechnology company has captured market attention with compelling trial results for its novel therapeutic candidate. Kodiak Sciences Inc....

The 2023 acquisition of biopharmaceutical firm Chinook Therapeutics by Swiss giant Novartis has culminated in a stark narrative of contrast....

Biotechnology firm Ocugen finds itself at a critical juncture, simultaneously managing a significant corporate setback and a promising new international...

Gene therapy specialist Krystal Biotech has achieved a significant regulatory milestone that is driving substantial investor interest. The company's flagship...

Shares of Vera Therapeutics experienced a notable upswing, closing at $26.15 after a robust 7% gain. This market movement was...

Trevi Therapeutics has seen its stock demonstrate notable strength in anticipation of upcoming clinical presentations. The biopharmaceutical company's shares climbed...

Eli Lilly and Company is executing an ambitious growth strategy through simultaneous manufacturing expansion and clinical development. The pharmaceutical giant...

Despite posting disappointing quarterly results and facing continued share price pressure, market analysts are demonstrating notable optimism toward CareDx. The...